See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Research Area · Cardiology

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
519510 11-dehydro Thromboxane B2 EIA Kit - Monoclonal New - 2012-02-08 225.763667638633 11-dehydro-thromboxane-b2-eia-kit-monoclonal 11-dehydro TXB2 ELISA Kit 11-dehydro-TXB2 enzymes immunoassays EIAs ELISAs kits assays measures measurements competitive quantification thromboxanes A2 TXA2 arachidonic acids platelets aggregation vascular bronchial smooth muscles hydrolyzed plasma urine ex vivo activation intra-renal production metabolites kidneys metabolized dehydrogenases enzymes cytosolic aldehydes peroxisomes peroxisomal b-oxidations beta-oxidations .beta.-oxidations β-oxidations infusions study studies circulating half-life t1/2 2,3-dinor 11-dehydro-2,3-dinor gas chromatography mass spectrometry GC/MS dosing doses aspirin acetylsalicylic acid NSAIDS nonsteroidal anti-inflammatory drugs smokers levels non-enzymatically 519501 225.763667638633
12730 15(S)-15-methyl Prostaglandin D2 85280-90-6 >95% 53.872375690607 15-s-15-methyl-prostaglandin-d2 15(S)-15-methyl PG2 15(S)-15-methyl-PGD2 prostaglandins vasoconstriction analogs 15S-15-methyl-PGD2 53.872375690607
12750 16,16-dimethyl Prostaglandin D2 64072-59-9 >98% 155.892154696133 16-16-dimethyl-prostaglandin-d2 16,16-dimethyl PGD2 16,16-dimethyl-PGD2 prostaglandins 155.892154696133
13050 1a,1b-dihomo Prostaglandin E1 - >98% 15.396279926335 1a-1b-dihomo-prostaglandin-e1 1a,1b-dihomo PGE1 1a,1b-dihomo-PGE1 prostaglandins 15.396279926335
9000462 2,3-dinor-6-keto Prostaglandin F1α-d9 (sodium salt) - ≥99% deuterated forms (d1-d9) 2010-05-07 20.369447513812 2-3-dinor-6-keto-prostaglandin-f1-d9-sodium-salt 2,3-dinor-6-keto PGF1α-d9 (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins PGs MS LC-MS LC/MS GC-MS GC/MS mass spectrometry deuterium deuterated 20.369447513812
515121 2,3-dinor-6-keto Prostaglandin F1α EIA Kit - 2006-05-23 148.800022099447 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays 148.800022099447
15120 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) - ≥95% 15.271049723756 2-3-dinor-6-keto-prostaglandin-f1-sodium-salt 2,3-dinor-6-keto PGF1α (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins 15.271049723756
13120 2,3-dinor Prostaglandin E1 7046-40-4 >98% 28.634060773480 2-3-dinor-prostaglandin-e1 2,3-dinor PGE1 prostaglandins 2,3-dinor-PGE1 erectile dysfunction 28.634060773480
11097 25-hydroxy Cholesterol New 2140-46-7 ≥98% 2012-02-08 1.138270922856 25-hydroxy-cholesterol 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 1.138270922856
11099 25-hydroxy Cholesterol-d6 New 88247-69-2 ≥99% deuterated forms (d1-d6) 2012-01-27 0.241974626560 25-hydroxy-cholesterol-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 0.241974626560
13260 6-keto Prostaglandin E1 67786-53-2 >99% 60.945441988950 6-keto-prostaglandin-e1 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins 60.945441988950
10007210 6-keto Prostaglandin E1 Lipid Maps MS Standard 67786-53-2 >99% 2008-11-03 40.630294659300 6-keto-prostaglandin-e1-lipid-maps-ms-standard 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 40.630294659300
15210 6-keto Prostaglandin F1α 58962-34-8 >99% 60.953138121546 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis 60.953138121546
515211 6-keto Prostaglandin F1α EIA Kit - 332.470368409385 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays 332.470368409385
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 39.352254143646 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 39.352254143646
10010002 6-keto Testosterone Enanthate Exclusive - ≥98% ✓ 2007-07-12 0.206261510129 6-keto-testosterone-enanthate esters androgens testosterone heptanoate analogs endocrinology 0.206261510129
10010003 6α-Testosterone Enanthate Exclusive - ≥98% ✓ 2007-07-13 0.618784530387 6-testosterone-enanthate esters androgens testosterone heptanoate analogs 6alpha-testosterone enanthate 6.alpha.-Testosterone enanthate endocrinology 0.618784530387
10010004 6β-Testosterone Enanthate Exclusive - ≥98% ✓ 2007-07-13 0.206261510129 6-testosterone-enanthate 6beta-Testosterone enanthate 6.beta.-Testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology 0.206261510129
13360 8-iso Prostaglandin E1 21003-46-3 >98% 78.829300184162 8-iso-prostaglandin-e1 Ovinonic acid; 8-iso PGE1; 8-epi PGE1 8-iso-PGE1 8-epi-PGE1 8-isoprostanes vasoconstriction prostaglandins 78.829300184162
700260 Alanine Transaminase Activity Assay Kit - 2010-01-06 270.386205466498 alanine-transaminase-activity-assay-kit ALT Activity Assay Kit; ALAT Activity Assay Kit; Alanine Aminotransferase Activity Assay Kit; sGPT Activity Assay Kit; Serum Pyruvic Transaminase Activity Assay Kit alanines aminotransferases homodimeric cytoplasmic pyridoxal phosphate-enzymes cells cellular nitrogen metabolism amino acids transamination a-ketoglutarates alpha-ketoglutarates α-ketoglutarates pyruvates glutamates tissues livers kidneys heart brains glucose neuronal glutamates alanine-aminotransferases reactions diseases injury diabetes cirrhosis fatty hepatitis carcinomas mononucleosis muscular dystrophy cardiovascular serums plasmas samples lysates NADH oxidations lactate dehydrogenases LDH NAD+ assays kits measures measurements 270.386205466498
700420 Ascorbate Assay Kit - 2010-09-01 209.529591160221 ascorbate-assay-kit L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD 209.529591160221
10532 BayCysLT2 Exclusive 712313-33-2 ≥95% ✓ 2010-09-22 2.552633517495 baycyslt2 CAY10633 HAMI3379 cysLT2 receptors cardiovascular disease antagonists leukotrienes LTC4 LTD4 cysteinyl HAMI 3379 HAMI-3379 cyslts CAY10633 CAY-10633 CAY 10633 2.552633517495
11073 Bisindolylmaleimide XI (hydrochloride) New 145333-02-4 ≥98% 2012-03-21 37.214390955495 bisindolylmaleimide-xi-hydrochloride Ro 32-0432 131848-98-1 Ro32-0432 Ro-32-0432 Ro-320432 Ro 320432 Ro320432 PKC isozymes Staurosporine inhibitors inhibits inhibition proteins kinases C PKCα PKCβI PKCε hydrochloride HCl cells hearts T-cell T cell inflammatory inflammation 37.214390955495
10155 BM 567 284464-77-3 >98% 2005-03-31 43.370676795580 bm-567 platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege 43.370676795580
10489 Candesartan cilexetil 145040-37-5 ≥98% 2011-04-08 57.833971761817 candesartan-cilexetil TCV-116 angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive 57.833971761817
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 55.690121546961 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 55.690121546961
10012447 CG 4305 - ≥95% 2010-05-12 49.515730071033 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 49.515730071033
600440 Cholesterol Uptake Cell-Based Assay Kit - 2011-06-28 42.757211797601 cholesterol-uptake-cell-based-assay-kit assays kits measures measurements cells hormones intermediates bile acids biosynthesis body cholesterols homeostasis de novo dietary absorption biliary clearance excretion plasma hypercholesterolemia cardiovascular diseases serum hepatic Ezetimibe inhibitors inhibits inhibition intestinal uptake enterocytes proteins Niemann-Pick C1 Like 1 NPC1L1 genes influx efflux intraluminal molecules membranes modulators NBD cultured U18666A inhibitor inhibits inhibition positive controls U 18666A U-18666A 42.757211797601
10956 Clofibrate 637-07-0 ≥98% 2004-09-14 10.768753836709 clofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate 10.768753836709
13657 (±)-Clopidogrel (hydrochloride) 90055-48-4 ≥98% 2011-04-11 4.077348066299 -clopidogrel-hydrochloride platelets aggregation antagonists P2Y12 receptors ADPs prodrugs anti-thrombic antithrombic 4.077348066299
700630 Creatine Kinase Fluorometric Assay Kit New - 2012-03-23 106.765634499519 creatine-kinase-fluorometric-assay-kit CK assays kits measures measurements CK kinases phosphokinases CPK catalyzes phosphorylations ATP adenosine 5'-triphosphates phosphocreatine ADP 5'-diphosphates energy storage phosphates muscles cells cytosolic cytosol enzymes two 2 subunits B brain-type M muscle-type isoenzymes CK-BB CPK-1 brains lungs CK-MB CPK-3 skeletal mitochondrial ubiquitous sarcomeric blood humans myocardial infarction hearts attacks rhabdomyolysis muscular dystrophy renal failure kidneys serums cholesterols levels statins T3 thyroid diseases hypothyroidism alcoholic livers rheumatiod arthritis total enzyme-coupled reactions rxns 106.765634499519
11326 Cyclopiazonic Acid New 18172-33-3 ≥95% 2012-02-23 38.231529337214 cyclopiazonic-acid NSC 117181 inhibitors SERCA calcium Ca2+-ATPase ATPases smooth muscles endothelial cells endothelium cardiovascular vascular biology cardiology mycotoxins Penicillium Aspergillus NSC117181 NSC-117181 38.231529337214
10012582 Diallyl Disulfide New 2179-57-9 ≥90% 2012-03-12 25.438090853284 diallyl-disulfide Garlicin; DADS; NSC 29228 disulphide dipropenyl H2S hydrogen sulfide cardiovascular diseases neuroscience vascular tone vasorelaxation neuroprotection cardiology hypertension signal transduction NSC29228 NSC-29228 garlic plants allicin 25.438090853284
13352 EHNA (hydrochloride) 58337-38-5 ≥98% 2011-10-07 766.115469613259 ehna-hydrochloride 51350-19-7 79763-32-9 59262-86-1 ADA reversible adenosine deaminase inhibitors inhibits inhibition cGMP PDE2 potent PDE1 PDE3 PDE4 phosphodiesterase ardioprotective ischemia stem cells 766.115469613259
10005056 Eicosapentaenoic Acid-d5 145191-14-6 ≥99% deuterated forms (d1-d5) 2005-08-30 291.556055248619 eicosapentaenoic-acid-d5 EPA-d5; Timnodonic Acid-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory 291.556055248619
11578 Eprosartan (mesylate) New 144143-96-4 ≥98% 2012-05-16 90.719337016575 eprosartan-mesylate SKF 108566J cardiovascular diseases hypertension angiotensin II rennin blood pressure ARB receptors blockers antagonists AT1 mesylate nervous system nerves vessels 90.719337016575
10007432 FABP3 (human recombinant) - ≥95% 2005-07-27 9.298664825046 fabp3-human-recombinant Heart-FABP; Fatty Acid Binding Protein-3; H-FABP protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology 9.298664825046
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 5.425531000613 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting 5.425531000613
10009549 FABP4 (human recombinant) - ≥90% 2007-06-15 16.343603909902 fabp4-human-recombinant A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 16.343603909902
9001068 FABP4 (human recombinant) FITC conjugated - ≥95% 2011-08-23 6.631610102604 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 6.631610102604
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 3.441008287292 fabp4-human-recombinant-western-ready-control Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 3.441008287292
10005191 FABP4 (mouse recombinant) - ≥95% 2005-07-27 6.236795580110 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 6.236795580110
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 2.515782688766 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 2.515782688766
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 12.769097605892 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 12.769097605892
700300 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit - 2011-07-28 112.190172018556 glucose-6-phosphate-dehydrogenase-activity-assay-kit G6PDH kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent 112.190172018556
13311 Gö 6983 133053-19-7 ≥98% 2009-10-07 9.212635422620 g-6983 proteins kinases C PKC α β γ δ ζ µ hearts cardioprotection ischemia reperfusion injuries contractile dyfunction alpha beta gamma delta zeta micro Goe Goe6983 Go-6983 Go 6983 9.212635422620
10580 HAMI3379 Exclusive 712313-35-4 ≥90% ✓ 2011-03-14 89.886527229676 hami3379 cysLT2 receptors cardiovascular diseases antagonists leukotrienes LTC4 LTD4 cysteinyl LTs CysLTs perfusion pressure decrease contractility cyclohexanecarboxylic acids 89.886527229676
13705 HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28) - 2009-12-01 0E-12 hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 0E-12
13707 HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37) - 2009-12-01 0E-12 hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP 0E-12
13708 HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28) - 2009-12-01 0E-12 hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 0E-12
13709 HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10) - 2009-12-02 0E-12 hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates 0E-12
10009377 HDAC2 (human recombinant) - ≥70% by SDS-PAGE 2006-12-06 23.566802079947 hdac2-human-recombinant Histone Deacetylase 2 HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active 23.566802079947
10009379 HDAC5 (human recombinant) - ≥90% by SDS-PAGE 2006-12-06 32.033977900551 hdac5-human-recombinant Histone Deacetylase 5 HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active 32.033977900551
10009466 HDAC9 (human recombinant) - ≥95% 2007-06-14 16.569378453038 hdac9-human-recombinant GenBank Accession No. NM 178423; Histone Deacetylase 9 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active 16.569378453038
700540 Hemoglobin Colorimetric Assay Kit - 2011-05-23 152.475832182319 hemoglobin-colorimetric-assay-kit kits assays measures measurements Hb Hgb globular proteins oxygen O2 lungs tissues cells carbon dioxide CO2 erythrocytes human molecules subunits chains heme groups charged iron Fe Fe2+ tetrapyrrole rings porphyrin covalent bonds monoxide nitric oxides NO hypoxia thiol S-nitrosothiol vasodilatory effects transport hypoxic red blood RBCs vessels sickle-cell anemia thalassemia bone marrow diseases kidney diabetes 152.475832182319
13624 Icariin 489-32-7 ≥97% 2010-02-11 1.115469613259 icariin PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans 2 Phenyl Benzopyrans 2-Phenyl-Chromenes 2 Phenyl Chromenes Bioflavonoids Flavonoids 1.115469613259
13711 KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10) - 2009-12-02 0E-12 kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate 0E-12
13714 Kir2.1 Potassium Channel Monoclonal Antibody (Clone S21-32) - 2009-12-02 0E-12 kir2-1-potassium-channel-monoclonal-antibody-clone-s21-32 channels antibodies western blots blotting immunoblotting WB immunohistochemistry IHC KCNJ2 genes Andersen-Tawil syndromes Andersen Tawil AT defects 0E-12
13715 Kir2.2 Potassium Channel Monoclonal Antibody (Clone S24-1) - 2009-12-02 0E-12 kir2-2-potassium-channel-monoclonal-antibody-clone-s24-1 channels ions antibodies western blots blotting immunoblotting WB immunohistochemistry IHC syndromes Smith-Magenis Smith Magenis chromosomes 17 seventeen tissues genes 0E-12
13716 Kir2.3 Potassium Channel Monoclonal Antibody (Clone S25-35) - 2009-12-04 0E-12 kir2-3-potassium-channel-monoclonal-antibody-clone-s25-35 antibodies channels ions western blots blotting immunoblotting WB IHC immunohistochemistry genes proteins potassiums 0E-12
13810 Limaprost 74397-12-9 >98% 49.011519337017 limaprost 17α,20-dimethyl-Δ2-Prostaglandin E1; 17α,20-dimethyl-Δ2-PGE1 PGE1 analogs inhibitors platelets aggregation prostaglandins 49.011519337017
390150 Linoleic Acid-d4 Exclusive 79050-23-0 ≥99% deuterated forms (d1-d4) ✓ 9.927914364641 linoleic-acid-d4 standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids 9.927914364641
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 2.875414364640 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes 2.875414364640
13357 Milrinone 78415-72-2 ≥98% 2011-03-07 310.264618784530 milrinone Primacor®; WIN 47203 inhibitors phosphodiesterases PDE3A PDE3B cAMP vascular diseases cardiovascular effects Sanofi Synthelabo Brand of Milrinone Lactate Sanofi Winthrop Brand of Milrinone Lactate Sanofi Synthelabo Brand of Milrinone Sanofi Brand of Milrinone Lactate Lactate Milrinone Milrinone Lactate Win-47203 Win 47203 Milrinone Corotrope Win47203 Primacor Corotrop inhibits inhibition 310.264618784530
585001 Myeloperoxidase (human) EIA Kit - 2009-05-05 34.002154696132 myeloperoxidase-human-eia-kit MPO (human) EIA Kit myeloperoxidases controls standards EIAs ELISAs enzymes immunometrics assays leukocytes oxidants atherosclerotic atherosclerosis plaques prothrombogenicity cytotoxic cytotoxins nitric oxides vasocontrictions vasocontrictors plasma blood ACS acute coronary syndromes cardiac myocardial infarction revascularization death assays 34.002154696132
700170 Myeloperoxidase Inhibitor Screening Assay Kit - 2009-04-14 99.838640883977 myeloperoxidase-inhibitor-screening-assay-kit MPO Inhibitor Screening Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays 99.838640883977
700160 Myeloperoxidase Peroxidation Assay Kit - 2009-04-14 110.108651933701 myeloperoxidase-peroxidation-assay-kit MPO Peroxidation Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 110.108651933701
9000537 N-Desethylamiodarone (hydrochloride) 96027-74-6 ≥95% 2009-10-07 5.834254143646 n-desethylamiodarone-hydrochloride MDEA substrates CYP3A4 metabolites amiodarone cytochromes CYP-3A4 CYP 3A4 5.834254143646
11106 Nifedipine 21829-25-4 ≥98% 2011-11-22 0.798342541436 nifedipine Nifediac™; BAY 1040; Procardia™; Adalat™; Nifedical™; Cordipin dihydropyridine calcium channel blockers Ca2+ hypertension angina endothelia cardiology preterm labor Raynaud’s phenomenon pulmonary edema coronary vasodilator antioxidant gastric acids 11104-22-6 101539-70-2 101554-38-5 adalat nifediac cordipin procardia nifedical adalate adapine adapress alat alfadat alonix angipec anifed BAY-1040 BAY1040 BAY-a BAYa BAY-a 1040 bonacid calcigard calcibloc calciguard calcilat camont cardifen cardionorm chronadalate coral cordafen cordaflex cordilan corinfar corotrend corynphar depin dignokonstant dilafed dilcor duranifin ecodipin fedcor fenamon fedipin fenihidine glopir hadipine hexadilat introcar kordafen macorel megalat myogard nifedilat nifedirex nifelantern nifelat nifensar niphedipine nyefax orix oxcord pidilat procardia sepamit TN 873R TN-873R TN873R tensopin tibricol UV-ENP 349PINa vasdalat vasofed xinran zenusin 0.798342541436
10010653 Nisoldipine-d4 1219795-47-7 ≥99% deuterated forms (d1-d4) 2009-04-15 0E-12 nisoldipine-d4 63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
11614 Olmesartan Medoxomil New 144689-63-4 ≥98% 2012-05-18 99.077747084100 olmesartan-medoxomil Olmetec; Benicar; CS 866 prodrugs angiotensin II receptors antagonists blood pressure hypertension cardiovascular disease atherosclerosis CS866 CS 866 in vivo RNH-6270 RNH 6270 RNH6270 AT1 AT2 blood pressure cardiovascular parameters CS-866 99.077747084100
10350 PRMT1 (human recombinant) - ≥80% 2011-01-25 112.131740860628 prmt1-human-recombinant Protein Arginine Methyltransferase 1 PRMT1 brucei Prmt1 TbPRMT1 brucei Silencing Factors Transcriptional Transcriptional Silencing Factors Transcription Factors Repressor Molecules Proteins Repressor Repressor Proteins arginine methyltransferase histones modification glycine arginine rich GAR motifs SAM-dependent GST-tagged active 112.131740860628
10752 PRMT6 (human recombinant) New - ≥80% 2012-01-24 8.669677008074 prmt6-human-recombinant Protein Arginine Methyltransferase 6; HRMT1L6; Histone Arginine N-methyltransferase PRMT6; Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 6 PRMTs arginine methyltransferases epigenetics PRMT6 histones SAM MMA aDMA H3R2 HMA H3K4 MLL HMGA1a active 8.669677008074
512031 Prostaglandin D2 EIA Kit - 2010-07-19 203.609714548802 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 203.609714548802
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 105.423217169570 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 105.423217169570
12990 Prostaglandin D3 Exclusive 71902-47-1 >98% ✓ 72.632799263352 prostaglandin-d3 PGD3 PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins 72.632799263352
13010 Prostaglandin E1 745-65-3 >98% 48.090448127685 prostaglandin-e1 Alprostadil; PGE1 PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 48.090448127685
13010.1 Prostaglandin E1 Analytical Reference Standard 745-65-3 >99% 33.304401473296 prostaglandin-e1-analytical-reference-standard Alprostadil; PGE1 PGE1 vasodilation USP erectile dysfunction prostaglandins 33.304401473296
13082 Resorcinolnaphthalein 41307-63-5 ≥98% 2009-02-24 48.882817679557 resorcinolnaphthalein NSC 354317 angiotensin converting enzyme 2 ACE2 hypertension blood pressure activators fibrosis 48.882817679557
10012555 Sodium Hydrogen Sulfide (hydrate) 207683-19-0 ≥65% 2009-09-03 16.287560088776 sodium-hydrogen-sulfide-hydrate Sodium Hydrosulfide; NSC 158264; NaHS hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 16.287560088776
11615 Telmisartan New 144701-48-4 ≥98% 2012-05-09 89.077747084100 telmisartan Pritor; BIBR 277; Micardis BIBR 277SE BIBR277 BIBR-277 receptors antagonists blood pressure hypertension PPAR PPARγ atherosclerosis cardiovascular disease angiotensin hormones hearts myocardial infarction hypertrophy renal glomerulosclerosis 89.077747084100
10162 Treprostinil 81846-19-7 >98% 2005-08-30 75.237668508287 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 75.237668508287
18113 YM-53601 Exclusive 182959-33-7 ≥98% ✓ 2009-08-11 8.449790055248 ym-53601 squalene synthases inhibitors cholesterol triglycerides HMG-CoA reductase fibrates hyperlipidemia hypercholesterolemia lipid-lowering activities inhibitor inhibited 8.449790055248
90210 α-Linolenic Acid 463-40-1 >98% 13.907580110497 -linolenic-acid ALA fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic 13.907580110497
9000433 α-Linolenic Acid-d14 - ≥99% deuterated forms (d1-d14) 2010-09-13 8.445831798649 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 8.445831798649
10010001 Δ-6 Testosterone Enanthate Exclusive - ≥98% ✓ 2007-07-12 0.206261510129 -6-testosterone-enanthate DELTA-6-testosterone enanthate .DELTA.-6-testosterone enanthate .DELTA.6-testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology 0.206261510129
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?